- Home
- ADAG vs DOMH Comparison
ADAG vs DOMH Comparison
Compare ADAG & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- DOMH
- Stock Information
- Founded
- ADAG 2011
- DOMH 1967
- Country
- ADAG China
- DOMH United States
- Employees
- ADAG N/A
- DOMH N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- ADAG Health Care
- DOMH Health Care
- Exchange
- ADAG Nasdaq
- DOMH Nasdaq
- Market Cap
- ADAG 90.8M
- DOMH 74.7M
- IPO Year
- ADAG 2021
- DOMH N/A
- Fundamental
- Price
- ADAG $2.00
- DOMH $4.56
- Analyst Decision
- ADAG Strong Buy
- DOMH
- Analyst Count
- ADAG 1
- DOMH 0
- Target Price
- ADAG $8.00
- DOMH N/A
- AVG Volume (30 Days)
- ADAG 94.7K
- DOMH 209.2K
- Earning Date
- ADAG 08-05-2025
- DOMH 08-07-2025
- Dividend Yield
- ADAG N/A
- DOMH 7.22%
- EPS Growth
- ADAG N/A
- DOMH N/A
- EPS
- ADAG N/A
- DOMH N/A
- Revenue
- ADAG $103,204.00
- DOMH $24,891,000.00
- Revenue This Year
- ADAG $6,488.89
- DOMH N/A
- Revenue Next Year
- ADAG $57.50
- DOMH N/A
- P/E Ratio
- ADAG N/A
- DOMH N/A
- Revenue Growth
- ADAG N/A
- DOMH 630.80
- 52 Week Low
- ADAG $1.33
- DOMH $0.83
- 52 Week High
- ADAG $3.58
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- ADAG 56.27
- DOMH 37.29
- Support Level
- ADAG $1.87
- DOMH $4.38
- Resistance Level
- ADAG $2.17
- DOMH $5.30
- Average True Range (ATR)
- ADAG 0.17
- DOMH 0.34
- MACD
- ADAG 0.01
- DOMH -0.09
- Stochastic Oscillator
- ADAG 71.93
- DOMH 3.40
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.